Aemetis (AMTX) Misses Q3 EPS by 18c

Aemetis (NASDAQ: AMTX) reported Q3 EPS of ($0.37), $0.18 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $59.19 million versus the consensus estimate of $87.44 million.

For earnings history and earnings-related data on Aemetis (AMTX) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Klarna Group (KLAR) 46K contracts trade, share price down 21.5%
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41